R1256/20-CCM 1319

About this trial

Last updated 2 years ago

Study ID

R1256/20-CCM 1319

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

Accepting

45+ Years

All

Trial Timing

Started 3 years ago

The CV-PREVITAL study is a randomised clinical trial (RCT) controlled versus usual-care designed to compare the effectiveness of a mobile health (mHealth) intervention with that of usual care in reducing specific cardiovascular (CV) risk factors (in the short term) and the occurrence of vascular events (in the long term). Promoted by the Italian Network of Cardiology (ICN, a cardiovascular research network promoted by the Italian Ministry of Health), in collaboration with the Consorzio Sanità (Co.S., an Italian consortium of general practitioners), CV-PREVITAL aims to develop an innovative model of cardiovascular primary prevention and to validate it in a very large sample of subjects and in 'real life' conditions.

Inclusion Criteria

- Subjects aged ≥ 45 years

- Have given their consent to participate in the study

- Subjects who have a smartphone

Exclusion Criteria

- Current or previous cardiovascular disease (personal history of myocardial infarction, angina pectoris, arterial revascularization procedures, stroke, TIA, peripheral artery disease)

- Psychiatric disorders

- Participation in other clinical trials